Correlation Between Adma Biologics and Immunoprecise Antibodies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Adma Biologics and Immunoprecise Antibodies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adma Biologics and Immunoprecise Antibodies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adma Biologics and Immunoprecise Antibodies, you can compare the effects of market volatilities on Adma Biologics and Immunoprecise Antibodies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adma Biologics with a short position of Immunoprecise Antibodies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adma Biologics and Immunoprecise Antibodies.

Diversification Opportunities for Adma Biologics and Immunoprecise Antibodies

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Adma Biologics and Immunoprecise is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Adma Biologics and Immunoprecise Antibodies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunoprecise Antibodies and Adma Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adma Biologics are associated (or correlated) with Immunoprecise Antibodies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunoprecise Antibodies has no effect on the direction of Adma Biologics i.e., Adma Biologics and Immunoprecise Antibodies go up and down completely randomly.

Pair Corralation between Adma Biologics and Immunoprecise Antibodies

Given the investment horizon of 90 days Adma Biologics is expected to generate 1.21 times more return on investment than Immunoprecise Antibodies. However, Adma Biologics is 1.21 times more volatile than Immunoprecise Antibodies. It trades about 0.01 of its potential returns per unit of risk. Immunoprecise Antibodies is currently generating about -0.39 per unit of risk. If you would invest  205.00  in Adma Biologics on March 31, 2022 and sell it today you would lose (3.00)  from holding Adma Biologics or give up 1.46% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Adma Biologics  vs.  Immunoprecise Antibodies

 Performance (%) 
      Timeline 
Adma Biologics 
Adma Biologics Performance
4 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Adma Biologics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady primary indicators, Adma Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.

Adma Biologics Price Channel

Immunoprecise Antibodies 
Immunoprecise Performance
0 of 100
Over the last 90 days Immunoprecise Antibodies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in July 2022. The current disturbance may also be a sign of long term up-swing for the company investors.

Immunoprecise Price Channel

Adma Biologics and Immunoprecise Antibodies Volatility Contrast

 Predicted Return Density 
      Returns 

Pair Trading with Adma Biologics and Immunoprecise Antibodies

The main advantage of trading using opposite Adma Biologics and Immunoprecise Antibodies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adma Biologics position performs unexpectedly, Immunoprecise Antibodies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunoprecise Antibodies will offset losses from the drop in Immunoprecise Antibodies' long position.

Adma Biologics

Pair trading matchups for Adma Biologics

The idea behind Adma Biologics and Immunoprecise Antibodies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Immunoprecise Antibodies

Pair trading matchups for Immunoprecise Antibodies

Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go